Weed (BUDZ) Change in Account Payables (2010 - 2026)
Weed's (BUDZ) quarterly Change in Account Payables came in at $3028.0 in Q1 2026, up 14.01% year-on-year from $2656.0 in Q1 2025, and up 125.13% quarter-over-quarter from -$12049.0 in Q4 2025.
Weed (BUDZ) Change in Account Payables (2010 - 2026) Analysis & Trends
Weed's Change in Account Payables history runs 13 years deep, the most recent figure standing at $3028.0 for Q1 2026.
- On a quarterly basis, Change in Account Payables rose 14.01% year-over-year to $3028.0 in Q1 2026; TTM through Mar 2026 was $12734.0, a 55.81% decrease from a year earlier, with the FY2025 full-year figure at $12362.0, up 177.2% from the prior year.
- Change in Account Payables climbed to $3028.0 in Q1 2026 per BUDZ's latest filing, from -$12049.0 in the prior quarter.
- Across five years, Change in Account Payables topped out at $65626.0 in Q4 2022 and bottomed at -$114911.0 in Q2 2022.
- The 5-year median for Change in Account Payables is $1393.0 (2025), against an average of -$3700.9.
- Biggest YoY gain for Change in Account Payables was 1411.47% in 2022; the steepest drop was 779.67% in 2022.
- Year by year, Change in Account Payables stood at $65626.0 in 2022, then tumbled by 45.2% to $35960.0 in 2023, then slumped by 190.75% to -$32634.0 in 2024, then jumped by 63.08% to -$12049.0 in 2025, then surged by 125.13% to $3028.0 in 2026.
- Per Business Quant, the three latest BUDZ Change in Account Payables figures stand at $3028.0 (Q1 2026), -$12049.0 (Q4 2025), and $1393.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 62.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 30.60 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 32.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Weed | 3.72 Mn | 3.72 Mn | - | 3,028.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3,028.00 |
| Mar 31, 2026 | 3,028.00 |
| Dec 31, 2025 | -12,049.00 |
| Dec 31, 2025 | -12,049.00 |
| Sep 30, 2025 | 1,393.00 |
| Sep 30, 2025 | 1,393.00 |
| Jun 30, 2025 | 20,362.00 |
| Jun 30, 2025 | 20,362.00 |
| Mar 31, 2025 | 2,656.00 |
| Mar 31, 2025 | 2,656.00 |
| Dec 31, 2024 | -32,634.00 |
| Dec 31, 2024 | -32,634.00 |
| Sep 30, 2024 | 23,410.00 |
| Sep 30, 2024 | 23,410.00 |
| Jun 30, 2024 | 35,385.00 |
| Jun 30, 2024 | 35,385.00 |
| Mar 31, 2024 | -42,174.00 |
| Mar 31, 2024 | -42,174.00 |
| Dec 31, 2023 | 35,960.00 |
| Dec 31, 2023 | 35,960.00 |